<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30072748</PMID>        <DateRevised>            <Year>2018</Year>            <Month>08</Month>            <Day>07</Day>        </DateRevised>        <Article PubModel="Electronic">            <Journal>                <ISSN IssnType="Electronic">2045-2322</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>8</Volume>                    <Issue>1</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Aug</Month>                        <Day>02</Day>                    </PubDate>                </JournalIssue>                <Title>Scientific reports</Title>                <ISOAbbreviation>Sci Rep</ISOAbbreviation>            </Journal>            <ArticleTitle>MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer.</ArticleTitle>            <Pagination>                <MedlinePgn>11584</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-018-29917-2</ELocationID>            <Abstract>                <AbstractText>Breast cancer is a heterogeneous disease with distinct molecular subtypes including the aggressive subtype triple-negative breast cancer (TNBC). We compared blood-borne miRNA signatures of early-stage basal-like (cytokeratin-CK5-positive) TNBC patients to age-matched controls. The miRNAs of TNBC patients were assessed prior to and following platinum-based neoadjuvant chemotherapy (NCT). After an exploratory genome-wide study on 21 cases and 21 controls using microarrays, the identified signatures were verified independently in two laboratories on the same and a new cohort by RT-qPCR. We differentiated the blood of TNBC patients before NCT from controls with 84% sensitivity. The most significant miRNA for this diagnostic classification was miR-126-5p (two tailed t-test p-value of 1.4 × 10<sup>-5</sup>). Validation confirmed the microarray results for all tested miRNAs. Comparing cancer patients prior to and post NCT highlighted 321 significant miRNAs (among them miR-34a, p-value of 1.2 × 10<sup>-23</sup>). Our results also suggest that changes in miRNA expression during NCT may have predictive potential to predict pathological complete response (pCR). In conclusion we report that miRNA expression measured from blood facilitates early and minimally-invasive diagnosis of basal-like TNBC. We also demonstrate that NCT has a significant influence on miRNA expression. Finally, we show that blood-borne miRNA profiles monitored over time have potential to predict pCR.</AbstractText>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Kahraman</LastName>                    <ForeName>Mustafa</ForeName>                    <Initials>M</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5536-048X</Identifier>                    <AffiliationInfo>                        <Affiliation>Clinical Bioinformatics, Saarland University, Homburg, Germany.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Hummingbird Diagnostics GmbH, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Röske</LastName>                    <ForeName>Anne</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Hummingbird Diagnostics GmbH, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Laufer</LastName>                    <ForeName>Thomas</ForeName>                    <Initials>T</Initials>                    <AffiliationInfo>                        <Affiliation>Hummingbird Diagnostics GmbH, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fehlmann</LastName>                    <ForeName>Tobias</ForeName>                    <Initials>T</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-1967-2918</Identifier>                    <AffiliationInfo>                        <Affiliation>Clinical Bioinformatics, Saarland University, Homburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Backes</LastName>                    <ForeName>Christina</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Clinical Bioinformatics, Saarland University, Homburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kern</LastName>                    <ForeName>Fabian</ForeName>                    <Initials>F</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-8223-3750</Identifier>                    <AffiliationInfo>                        <Affiliation>Clinical Bioinformatics, Saarland University, Homburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kohlhaas</LastName>                    <ForeName>Jochen</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Hummingbird Diagnostics GmbH, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schrörs</LastName>                    <ForeName>Hannah</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Hummingbird Diagnostics GmbH, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Saiz</LastName>                    <ForeName>Anna</ForeName>                    <Initials>A</Initials>                    <AffiliationInfo>                        <Affiliation>Hummingbird Diagnostics GmbH, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Zabler</LastName>                    <ForeName>Cassandra</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Hummingbird Diagnostics GmbH, Heidelberg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ludwig</LastName>                    <ForeName>Nicole</ForeName>                    <Initials>N</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Human Genetics, Saarland University, Homburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Fasching</LastName>                    <ForeName>Peter A</ForeName>                    <Initials>PA</Initials>                    <AffiliationInfo>                        <Affiliation>Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Strick</LastName>                    <ForeName>Reiner</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Rübner</LastName>                    <ForeName>Matthias</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Beckmann</LastName>                    <ForeName>Matthias W</ForeName>                    <Initials>MW</Initials>                    <AffiliationInfo>                        <Affiliation>Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Meese</LastName>                    <ForeName>Eckart</ForeName>                    <Initials>E</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Human Genetics, Saarland University, Homburg, Germany.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Keller</LastName>                    <ForeName>Andreas</ForeName>                    <Initials>A</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0002-5361-0895</Identifier>                    <AffiliationInfo>                        <Affiliation>Clinical Bioinformatics, Saarland University, Homburg, Germany. andreas.keller@ccb.uni-saarland.de.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schrauder</LastName>                    <ForeName>Michael G</ForeName>                    <Initials>MG</Initials>                    <AffiliationInfo>                        <Affiliation>Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Obstetrics and Gynecology, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>08</Month>                <Day>02</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>England</Country>            <MedlineTA>Sci Rep</MedlineTA>            <NlmUniqueID>101563288</NlmUniqueID>            <ISSNLinking>2045-2322</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2017 Jan 4;45(D1):D90-D96</RefSource>                <PMID Version="1">27742822</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Methods. 2011 Sep 04;8(10):841-3</RefSource>                <PMID Version="1">21892151</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2014 Jun;40(5):595-604</RefSource>                <PMID Version="1">24286642</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2014 Oct 15;5(19):9484-97</RefSource>                <PMID Version="1">25344866</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncotarget. 2016 Jun 7;7(23):34288-99</RefSource>                <PMID Version="1">27144431</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2016 May 5;44(8):3865-77</RefSource>                <PMID Version="1">26921406</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Mol Life Sci. 2016 Aug;73(16):3169-81</RefSource>                <PMID Version="1">26874686</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2015 Jul;152(1):183-191</RefSource>                <PMID Version="1">26062749</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2014 Nov 04;9(11):e111644</RefSource>                <PMID Version="1">25369468</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast. 2015 Aug;24(4):364-9</RefSource>                <PMID Version="1">25957467</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2014 Aug 1;30(15):2237-8</RefSource>                <PMID Version="1">24651967</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2014 May;138(5):595-601</RefSource>                <PMID Version="1">24236805</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Epigenetics. 2016 Nov 21;8:123</RefSource>                <PMID Version="1">27895807</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2011 Jan;125(1):145-56</RefSource>                <PMID Version="1">21042932</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Aging (Albany NY). 2017 Mar 23;9(3):932-954</RefSource>                <PMID Version="1">28340489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Med. 2014 Dec 03;12:224</RefSource>                <PMID Version="1">25465851</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2012;7(1):e29770</RefSource>                <PMID Version="1">22242178</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2015 Mar;65(2):87-108</RefSource>                <PMID Version="1">25651787</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Genomics. 2014 Jun 14;15:474</RefSource>                <PMID Version="1">24928098</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Anal Chem. 2016 Feb 16;88(4):2088-95</RefSource>                <PMID Version="1">26760198</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA Biol. 2012 Jun;9(6):900-10</RefSource>                <PMID Version="1">22664918</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2015 Feb 18;17:21</RefSource>                <PMID Version="1">25849621</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2010 Jul;38(13):4476-86</RefSource>                <PMID Version="1">20299343</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Neuroinflammation. 2015 Oct 31;12:196</RefSource>                <PMID Version="1">26521232</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Clin Cancer Res. 2015 Mar 1;21(5):1207-14</RefSource>                <PMID Version="1">25547678</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Arch Pathol Lab Med. 2010 Jul;134(7):e48-72</RefSource>                <PMID Version="1">20586616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA Biol. 2016 Nov;13(11):1084-1088</RefSource>                <PMID Version="1">27687236</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncol Res. 2016;23(6):291-302</RefSource>                <PMID Version="1">27131315</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2016 Apr 7;44(6):e53</RefSource>                <PMID Version="1">26635395</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS One. 2015 Nov 23;10(11):e0143321</RefSource>                <PMID Version="1">26599228</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Treat Res. 2017 Feb;92(2):55-66</RefSource>                <PMID Version="1">28203552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Lab Med. 2015 Mar;35(2):226-32</RefSource>                <PMID Version="1">25729725</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMC Res Notes. 2009 May 19;2:89</RefSource>                <PMID Version="1">19454029</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2017</Year>                <Month>05</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>09</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>8</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>epublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30072748</ArticleId>            <ArticleId IdType="doi">10.1038/s41598-018-29917-2</ArticleId>            <ArticleId IdType="pii">10.1038/s41598-018-29917-2</ArticleId>            <ArticleId IdType="pmc">PMC6072710</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>